Escalon Medical Statistics
Total Valuation
Escalon Medical has a market cap or net worth of 1.69 million. The enterprise value is 5,796.
| Market Cap | 1.69M |
| Enterprise Value | 5,796 |
Important Dates
The next estimated earnings date is Friday, May 22, 2026.
| Earnings Date | May 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Escalon Medical has 7.42 million shares outstanding. The number of shares has increased by 16.28% in one year.
| Current Share Class | 7.42M |
| Shares Outstanding | 7.42M |
| Shares Change (YoY) | +16.28% |
| Shares Change (QoQ) | +0.60% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 7.91% |
| Float | 7.27M |
Valuation Ratios
The trailing PE ratio is 1.86.
| PE Ratio | 1.86 |
| Forward PE | n/a |
| PS Ratio | 0.15 |
| PB Ratio | 0.41 |
| P/TBV Ratio | 0.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.01 |
| EV / Sales | 0.00 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.04 |
Financial Position
The company has a current ratio of 2.59, with a Debt / Equity ratio of 0.24.
| Current Ratio | 2.59 |
| Quick Ratio | 1.85 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | -7.02 |
| Interest Coverage | -55.03 |
Financial Efficiency
Return on equity (ROE) is 57.49% and return on invested capital (ROIC) is -14.04%.
| Return on Equity (ROE) | 57.49% |
| Return on Assets (ROA) | -8.78% |
| Return on Invested Capital (ROIC) | -14.04% |
| Return on Capital Employed (ROCE) | -17.90% |
| Weighted Average Cost of Capital (WACC) | 3.44% |
| Revenue Per Employee | 293,470 |
| Profits Per Employee | 23,455 |
| Employee Count | 39 |
| Asset Turnover | 1.80 |
| Inventory Turnover | 3.94 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.49% in the last 52 weeks. The beta is 0.09, so Escalon Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.09 |
| 52-Week Price Change | -35.49% |
| 50-Day Moving Average | 0.19 |
| 200-Day Moving Average | 0.22 |
| Relative Strength Index (RSI) | 55.48 |
| Average Volume (20 Days) | 40,147 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Escalon Medical had revenue of 11.45 million and earned 914,752 in profits. Earnings per share was 0.12.
| Revenue | 11.45M |
| Gross Profit | 4.75M |
| Operating Income | -895,045 |
| Pretax Income | 1.85M |
| Net Income | 914,752 |
| EBITDA | -866,906 |
| EBIT | -895,045 |
| Earnings Per Share (EPS) | 0.12 |
Balance Sheet
The company has 3.34 million in cash and 1.01 million in debt, with a net cash position of 2.33 million or 0.31 per share.
| Cash & Cash Equivalents | 3.34M |
| Total Debt | 1.01M |
| Net Cash | 2.33M |
| Net Cash Per Share | 0.31 |
| Equity (Book Value) | 4.15M |
| Book Value Per Share | 0.47 |
| Working Capital | 4.03M |
Cash Flow
In the last 12 months, operating cash flow was -135,664 and capital expenditures -8,301, giving a free cash flow of -143,965.
| Operating Cash Flow | -135,664 |
| Capital Expenditures | -8,301 |
| Depreciation & Amortization | 28,139 |
| Net Borrowing | -135,924 |
| Free Cash Flow | -143,965 |
| FCF Per Share | -0.02 |
Margins
Gross margin is 41.48%, with operating and profit margins of -7.82% and 16.18%.
| Gross Margin | 41.48% |
| Operating Margin | -7.82% |
| Pretax Margin | 16.18% |
| Profit Margin | 16.18% |
| EBITDA Margin | -7.57% |
| EBIT Margin | -7.82% |
| FCF Margin | n/a |
Dividends & Yields
Escalon Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.28% |
| Shareholder Yield | -16.28% |
| Earnings Yield | 54.04% |
| FCF Yield | -8.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 24, 1997. It was a reverse split with a ratio of 0.25.
| Last Split Date | Nov 24, 1997 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |